Symbol Lookup
CYCLACEL 6% CP (NSDQ: CYCCP) 

Company Quote
 
Stock Data
Last Price 3.50 (08.26.10 8:10 PM EDT)
Change (%)     - (-)
Volume -
Open -
Previous Close 3.50
Day High 3.50
Day Low 3.50
Bid 3.50 x 500
Ask 3.82 x 100
 
Average Volume 369
Shares Outstanding 2.99M
Market Cap 10.5M
Year High 4.60
Year Low 1.25
Earnings Per Share N/A
P/E Ratio N/A
Dividend 0.60
Yield 17.14
Chart
 
Related Companies
Symbol Last Change (%)
ALMD 0.62 +0.01 (+1.31%)
CHIO 0.28 -0.00 (-0.35%)
GTCB 0.33 -0.04 (-10.81%)
TSC 2.61 +0.00 (+0.00)
ALINN 5.95 +0.15 (+2.59%)
MBRX 0.31 +0.00 (+0.00)
NVD 0.17 +0.00 (+0.00)
News: CYCCP
Thu, Jul 01, 2010
Cyclacel Pharma (CYCC) Gets Orphan Drug Designation from U.S. FDA for CYC682 AML and MDS Treatment - StreetInsider
Fri, Apr 30, 2010
Cyclacel Pharmaceuticals (CYCC) Receives Patent Complaint Filed by Celgene (CELG) - StreetInsider
Wed, Jan 13, 2010
Cyclacel Pharmaceuticals (CYCC) Completes Direct Offering - StreetInsider
Thu, Jan 07, 2010
Cyclacel Pharma (CYCC) Announces Publications of Seliciclib CDK Inhibitor - StreetInsider
Fri, May 29, 2009
Cyclacel Pharmaceuticals (CYCCP) Announces Positive Interim Data From Phase 2 Trials of Oral Seliciclib - StreetInsider
Blogs: CYCCP
Thu, Jul 01, 2010
Arena Pharma shares jump on obesity drug deal. Cell Therapeutics clears 2010 debt, shares rise - Biotech and Health C...
Thu, Jun 10, 2010
Cyclacel reports postive Phase II data. MannKind says insulin drug meets trial goal. Human Genome submits lupus drug for FDA approval - Biotech and Health C...
Fri, Apr 30, 2010
POZEN gets FDA nod, shareholders hang on for wild ride. After the bell, Middlebrook Pharmaceuticals files chapter 11 - Biotech and Health C...
Tue, Mar 23, 2010
RxNews Recap for Tuesday 03-23-10. Dynavax rises on positive Hep B Vaccine safety data. - Biotech and Health C...
Tue, May 01, 2007
Income expert's converible triple play - TheStockAdvisors.com
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
Bots go here
close window
E-mail Article to a Friend




CLOSE WINDOW